跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VECTIBIX panitumumab 100mg/5mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
VECTIBIX panitumumab 100mg/5mL concentrated injection vial
Approved
STANDARD
VECTIBIX panitumumab 100mg/5mL concentrated injection vial
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2213febb6cb5ba6f
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
2213febb6cb5ba6f
Product Name
VECTIBIX panitumumab 100mg/5mL concentrated injection vial
Artg Id
128270
Artg Name
VECTIBIX panitumumab 100mg/5mL concentrated injection vial
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2008-05-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/f9de6d3ce6a1d5cd7f38d655ef246a8a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/dcc5ab4727c061eaca2c9fc74ad94ee2.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2213febb6cb5ba6f
Type
Standard
Back to TGA Approvals